Table 2.
The calibrated ratios of PPRV H interaction with SLAM and site-directed mutants determined by co-IP
|
Group |
IP: Anti-HA |
IP: Anti-HA |
IP: Anti-Myc |
IP: Anti-Myc |
|---|---|---|---|---|
|
IB: Anti-HA |
IB: Anti-Myc |
IB: Anti-HA |
IB: Anti-Myc |
|
|
Hv and SLAM |
100.00 % |
100.00 % |
100.00 % |
100.00 % |
|
Hv and mSLAM1 |
97.84 % |
55.07 % |
36.99 % |
83.78 % |
|
Hv and mSLAM2 |
93.88 % |
89.50 % |
59.29 % |
88.22 % |
|
Hv and mSLAM3 |
104.68 % |
0.00 % |
0.00 % |
108.74 % |
|
mHv and SLAM |
91.97 % |
0.00 % |
0.00 % |
118.61 % |
|
mHv and mSLAM1 |
92.71 % |
0.00 % |
0.00 % |
113.50 % |
|
mHv and mSLAM2 |
90.67 % |
0.00 % |
0.00 % |
120.19 % |
|
mHv and mSLAM3 |
93.83 % |
0.00 % |
0.00 % |
117.74 % |
|
Hv and EGFP |
90.07 % |
0.00 % |
0.00 % |
0.00 % |
|
mHv and EGFP |
90.49 % |
0.00 % |
0.00 % |
0.00 % |
|
EGFP and SLAM |
0.00 % |
0.00 % |
0.00 % |
101.59 % |